Prospero‐related homeobox 1 drives angiogenesis of hepatocellular carcinoma through selectively activating interleukin‐8 expression
Open Access
- 23 June 2017
- journal article
- research article
- Published by Wolters Kluwer Health in Hepatology
- Vol. 66 (6) , 1894-1909
Abstract
Angiogenesis has been proven to play an important role in the progression of hepatocellular carcinoma (HCC). However, the molecular mechanism underlying HCC angiogenesis is not well understood. In this study, Prospero‐related homeobox 1 (PROX1) was identified as a novel proangiogenic factor in HCC cell lines and tissues. A strong positive correlation was found between the levels of PROX1 and microvessel density in HCC tissues. Knockdown of PROX1 expression in HCC cells significantly inhibited the in vitro capillary tube formation by human vascular endothelial cells and in vivo angiogenesis of HCC, while overexpression of PROX1 in HCC cells induced the opposite effects. PROX1 and nuclear factor κB p65 expression levels were positively correlated in both HCC tissues and cell lines. PROX1 enhances the nuclear accumulation of p65 and stabilizes p65 by recruiting ubiquitin‐specific protease 7 to prevent p65 ubiquitination. Consequently, PROX1 activated nuclear factor κB signaling and selectively promoted expression of the proangiogenic interleukin‐8 (IL‐8) by epigenetically stimulating the IL‐8 promoter. Finally, progression of high PROX1 expression HCC in tumor xenograft mice could be effectively contained by an anti‐IL‐8 monoclonal antibody. Conclusions: We have identified PROX1 as a crucial promoter of HCC angiogenesis; our study provides an insight into PROX1's function in HCC progression and the potential therapeutic application of anti‐IL‐8 antibody in high PROX1 expression HCC patients. (Hepatology 2017;66:1894–1909)Keywords
Funding Information
- National Basic Research Program (2012CB519002, 2013CB91-0500)
- National Key Project for Infectious Diseases (2012ZX10002-006, 2012ZX10004-503, 2012ZX10002012-003, 2012ZX10002-012)
- Natural Science Foundation of China (81472226, 81461130019, 81572832, 81472671)
This publication has 35 references indexed in Scilit:
- MicroRNA-26a Suppresses Angiogenesis in Human Hepatocellular Carcinoma by Targeting Hepatocyte Growth Factor-cMet PathwayHepatology, 2013
- Constitutive Activation of Signal Transducer and Activator of Transcription 3 (STAT3) and Nuclear Factor κB Signaling in Glioblastoma Cancer Stem Cells Regulates the Notch PathwayJournal of Biological Chemistry, 2013
- Long noncoding RNA associated with microvascular invasion in hepatocellular carcinoma promotes angiogenesis and serves as a predictor for hepatocellular carcinoma patients' poor recurrence-free survival after hepatectomyHepatology, 2012
- Clinicopathological significance of nuclear factor‐κB activation in hepatocellular carcinomaHepatology Research, 2011
- Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008International Journal of Cancer, 2010
- Nuclear factor-κB in cancer development and progressionNature, 2006
- A hyper‐dynamic equilibrium between promoter‐bound and nucleoplasmic dimers controls NF‐κB‐dependent gene activityThe EMBO Journal, 2006
- Degradation of Promoter-bound p65/RelA Is Essential for the Prompt Termination of the Nuclear Factor κB ResponseJournal of Experimental Medicine, 2004
- The candidate tumour suppressor protein ING4 regulates brain tumour growth and angiogenesisNature, 2004
- NF-κB in cancer: from innocent bystander to major culpritNature Reviews Cancer, 2002